Skip to main content
Healthcare

STAT+: GLP-1s are given an FDA warning for rare eye condition risk

STAT+: GLP-1s are given an FDA warning for rare eye condition risk

Feed excerpt — reported by STAT News

The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.